Arvaya Healthcare Approves ₹15.49 Crore Preferential Share Swap Allotment
Bijoy Hans Ltd · Outcome · 24 Oct 2026, 11:19 pm
Arvaya Healthcare Approves ₹15.49 Crore Preferential Share Swap Allotment On 24th Oct'26, Arvaya Healthcare approved the preferential allotment of 38,71,854 equity shares at ₹40 per share (face value ₹10, premium ₹30), aggregating to ₹15.49 crore, to shareholders of Sushodha Institute of Gastroenterology on a share swap basis. Consequently, the company's paid-up equity capital expanded from ₹48.02 crore (4,80,21,857 shares) to ₹51.89 crore (5,18,93,711 shares). The newly issued shares carry pari-passu rights with existing equity and remain subject to statutory lock-in requirements pending listing approvals.
Original exchange filing (PDF)
More announcements from Bijoy Hans Ltd
- The investor call arranged by the company on 16th November,2026 was concluded successfully. Please find attached herewith Audio for the same. · 17 Nov 2026
- Investor Presentation in relation with the Unaudited Standalone and consolidated Financial Results of the Company for the quarter and half year ended on September 30 2026 and overall company .... · 16 Nov 2026
- Unaudited Standalone and Consolidated financial results for the quarter ended 30th September 2026 · 14 Nov 2026
- Statement of Deviation and Variation for the quarter ended 30th September 2026 is not applicable to the Company. · 14 Nov 2026
- Declaration of Unaudited standalone and consolidated Financial Results for the half year ended and 2nd quarter ended 30th September 2026 · 14 Nov 2026
- Revision in intimation and In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Arvaya Healthcare Limited (formerly known .... · 16 Nov 2026
- In compliance with the provisions of Regulation 30 of SEBI (LODR) Regulations 2015, we would like to inform you that Arvaya Healthcare Limited (formerly known as Bijoy Hans Limited) (''the .... · 16 Nov 2026
- Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Pursuant to the provisions .... · 13 Nov 2026
